lystn

Alex Gorsky Chairman and CEO, Johnson a Johnson “What we announced that day was that we have identified a lead candidate for COVID-19 vaccine…. This is a bit of a moonshot for us.” That’s Johnson a Johnson CEO Alex Gorsky talking about the $1 billion partnership his company formed with BARDA, the U.S. Biomedical Advanced Research and Development Authority. The company is ramping up so that if the accelerated clinical trials are successful, JaJ will be prepared to produce and ship by early 2021. Gorsky spoke with Mike Milken about lessons the company learned from its Ebola vaccine, how to keep a global workforce safe and healthy, and how his training at West Point and as a lieutenant and captain in the U.S. Army shapes his mission-driven leadership. The company recently approved a policy for its physicians and healthcare providers to take 14 weeks of paid leave to serve on the front lines of the crisis, helping them achieve the intensive-care credo that no patient dies alone.